United States. Congress. House. Committee on Oversight and Government Reform. (2010). Should FDA drug and medical device regulation bar state liability claims?: Hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, second session, May 14, 2008. U.S. G.P.O..
Chicago Style (17th ed.) CitationUnited States. Congress. House. Committee on Oversight and Government Reform. Should FDA Drug and Medical Device Regulation Bar State Liability Claims?: Hearing Before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, Second Session, May 14, 2008. Washington: U.S. G.P.O., 2010.
MLA (9th ed.) CitationUnited States. Congress. House. Committee on Oversight and Government Reform. Should FDA Drug and Medical Device Regulation Bar State Liability Claims?: Hearing Before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, Second Session, May 14, 2008. U.S. G.P.O., 2010.